Czech and Slovak Ophthalmology 493 Original article Ocular Disturbances as the First Sign of Decompensated Arterial Hypertension Stěpanov Alexandr https://orcid.org/0000-0002-8462-8756 Studnička Jan https://orcid.org/0000-0002-9911-4379 Hejsek Libor https://orcid.org/0000-0001-9973-8969 Jirásková Naďa Rozsíval Pavel https://orcid.org/0000-0001-6628-7954 18 9 2014 5 4

Arterial hypertension is a serious health problem. Decompensation of blood pressure may cause many ocular complications. We present three case reports of men with decompensated blood pressure and associated ocular complications. Successful compensation of blood pressure leads to objective improvement of fundus changes and vision.

 arterial hypertension hypertonic angiopathy retinopathy neuropathy References Abdelrahman, GS.: Intravitreal bevacizumab in persistent retinopathy secondary to malignant hypertension. Saudi J Ophthalmol, 2013; 27: 25–29. Grosso, A., Veglio, F., Porta, M. et al.: Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol, 2005; 89: 1646–1654. ChatterJee, S., Chattopadhya, S., Hope-Ross, M. et al.: Hypertensive and the Eye: changing perspective. J Hum Hypertens, 2002; 16(10): 667–75. Chobanian, AV.: Control of hypertension–an important national priority. N Engl J Med, 2001; 345: 534–535. Filipovský, J., Widimský, J., Ceral, J. et al.: Diagnostické a léčebné postupy u arteriální hypertenze. Kapitoly z kardiologie, 2013. Keith, N., Wagener, HP., Banker, N.: Some different types of essential hypertension. Their course and prognosis., AMJ Med Sci, 1939; 197: 332. Klein, R., Klein, BEK., Moss, SE.: The relation of systemic hypertension to changes in the retinal vasculature. The Beaver Dam Eye Study. Trans Am Ophthalmol, 1997; 95: 329–350. Klein, R., Klein, BEK., Moss, SE. et al: Hypertension and retinopathy, arteriolar narrowing and arteriovenous nicking in a population. Arch Ophthalmol, 1994; 112: 92–98. Klein, R., Sharrett, AR., Klein, BEK et al.: Are retinal arteriolar abnormalities related to atherosclerosis? The Atherosclerosis in Communities Study. Arterioscler Thromb Vasc Biol, 2000; 20: 1644–1650. Kumudini, S., Vikas, K., Priyadarshini, M. et al.: Hypertensive retinopathy. Clinical Queries Nephrology, 2013; 2: 136–139. Liebreich, R.: Ophthalmoscopic findings in Bright’s disease. Albrecht von Graefes Arch Ophthalmol, 1859; 5: 265–268. Mancia, G., Fagard, R, Narkiewicz, K et al.: ESH-ESC Guidelines 2007 Leitlinien der European Society of Hypertension. J Hypertension, 2007; 25: 1751–1762. Ojaimi, E., Nguyen, TT., Klein, R. et al.: Retinopathy signs in people without diabetes. The multi-ethnic study of atherosclerosis. Ophthalmology, 2011; 118: 656–662. Sharp, PS., Chaturvedi, N., Wormald, R. et al.: Hypertensive retinopathy in Afro-Caribbeans and Europeans. Prevalence and risk factor relationships. Hypertension, 1995; 25: 1322–1325. Stolk, RP., Vingerling, JR., de Jong, PT. et al.: Retinopathy, glucose, and insulin in an elderly population. The Rotterdam Study. Diabetes, 1995; 44: 11–15. Walsh, JB.: Hypertensive retinopathy: description, classification and prognosis. Ophthalmology, 1982; 89: 1127–1131. Wang, JJ., Mitchell, P., Leung, H. et al.: Hypertensive retinal vessel wall signs in the general older population: the Blue Mountains Eye Study. Hypertension, 2003, 42: 534–541. Wong, TY., Klein, R., Sharret, AR. et al.: The prevalence and risk factors of retinal microvascular abnormalities in older people. The Cardiovascular Health Study. Ophthalmology, 2003; 110: 658–666. Yu, T., Mitchell, P., Berry, G. et al.: Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol, 1998; 116: 83–89. Gorelick, PB.: New horizons for stroke prevention PROGRESS and HOPE., Lancet Neurology, 2002; 1: 149–156. Karen, I., Widimský, J.: Doporučené postupy pro praktické lékafie, Doporučení diagnostických a léčebných postupů u arteriální hypertenze., 2008, Společnost všeobecného lékařství, U Hranic 16, Praha 10. Wolf-Maier, K., Cooper, RS., Banegas, JR. et al.: Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA, 2003; 289: 2363–2369.